期刊文献+

The Expression of β3-adrenoceptor of Left Ventricle and the Effect on Heart Function by Stimulating β3-AR in Rats With Experimental Heart Failure

The Expression of β3-adrenoceptor of Left Ventricle and the Effect on Heart Function by Stimulating β3-AR in Rats With Experimental Heart Failure
下载PDF
导出
摘要 Objectives To observe the expression of β3-adrenoceptor (β3-AR) of left ventricle and the effect on heart function by stimulating β3-AR in rats with experimental heart failure. Methods Rats were randomly divided into heart failure group and control group. Heart failure models were built up by ligating coronary artery in rats. The expression of β3-AR mRNA were detected with RT-PCR; The change of heart function were observed after administration of BRL37344 (β3-AR agonist) by measuring left ventricular end-systolic pressure (LVESP), left ventricular end-diastolic pressure (LVEDP), the maximum pressure ascending rate of left ventricle (+dp/ dtmax) and the maximum pressure descending rate of left ventricle(-dp/dtmax). Results The expression of β3-AR mRNA (β3/β-actin) was 0.028±0.005 and the proportion of β3-AR (β3/β1+β2+β3) was 5.4%±0.06% in failure rats while the expression of β3-AR mRNA was 0.011 ±0.004 and the proportion was 1.2%±0.04% in control rats; The descending percentage of LVESP, + dp/dtmax and -dp/dtmax were 16.1%, 21.7% and 13.2% respectively with administration of BRL37344 in failure rats, while 12.2%, 15.8% and 11.5% in control rats. Conclusions Compared with control group the expression of β3-AR mRNA of left ventricle was obviously increased and the negative inotropic function with exciting β3-AR was obviously enhanced in failure groups. Objectives To observe the expression of β3-adrenoceptor (β3-AR) of left ventricle and the effect on heart function by stimulating β3-AR in rats with experimental heart failure. Methods Rats were randomly divided into heart failure group and control group. Heart failure models were built up by ligating coronary artery in rats. The expression of β3-AR mRNA were detected with RT-PCR; The change of heart function were observed after administration of BRL37344 (β3-AR agonist) by measuring left ventricular end-systolic pressure (LVESP), left ventricular end-diastolic pressure (LVEDP), the maximum pressure ascending rate of left ventricle (+dp/ dtmax) and the maximum pressure descending rate of left ventricle(-dp/dtmax). Results The expression of β3-AR mRNA (β3/β-actin) was 0.028±0.005 and the proportion of β3-AR (β3/β1+β2+β3) was 5.4%±0.06% in failure rats while the expression of β3-AR mRNA was 0.011 ±0.004 and the proportion was 1.2%±0.04% in control rats; The descending percentage of LVESP, + dp/dtmax and -dp/dtmax were 16.1%, 21.7% and 13.2% respectively with administration of BRL37344 in failure rats, while 12.2%, 15.8% and 11.5% in control rats. Conclusions Compared with control group the expression of β3-AR mRNA of left ventricle was obviously increased and the negative inotropic function with exciting β3-AR was obviously enhanced in failure groups.
出处 《South China Journal of Cardiology》 CAS 2005年第2期67-71,共5页 岭南心血管病杂志(英文版)
关键词 β3-adrenoceptors Heart failure β3-adrenoceptors Heart failure
  • 相关文献

参考文献2

二级参考文献10

  • 1韩启德.肾上腺素受体研究进展[J].生理科学进展,1995,26(2):103-109. 被引量:14
  • 2WangJ ZhuSJ In: Zhu SJ Xu CB eds.Neural hormone-receptor and heart failure[A].In: Zhu SJ, Xu CB, eds.Bases and Clinics of Heart Failure(心力衰竭基础与临床)[M].Beijing: People′s Surgeon Publishing House,2001.88-96. 被引量:1
  • 3Liggett SB, Freedman NJ, Schwinn DA, Lefkowitz RJ. Structural basis for receptor subtype-specific regulation revealed by a chimeric β3/β2-adrenergic receptor[J]. Proc Natl Acad Sci USA, 1993, 90(8):3665-3669. 被引量:1
  • 4Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium[J]. Circulation, 2001, 103(12):1649-1655. 被引量:1
  • 5Gauthier C, Tavernier G, Trochu JN, Leblais V, Laurent K, Langin D, et al. Interspecies differences in the cardiac negative inotropic effects of β3-adrenoceptor agonists[J]. J Pharmacol Exp Ther, 1999, 290(2):687-693. 被引量:1
  • 6Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay AT, Altan VM. The effect of diabetes on expression of β1-, β2-, and β3-adrenoreceptors in rat hearts[J]. Diabetes, 2001, 50(2):455-461. 被引量:1
  • 7Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats[J]. Circ Res, 1994, 75(1):105-113. 被引量:1
  • 8Suzuki M, Ohte N, Wang ZM, Williams DL Jr, Little WC, Cheng CP. Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy[J]. Cardiovasc Res, 1998, 39(3):589-599. 被引量:1
  • 9Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy[J]. Circulation, 1999, 99(23):3009-3016. 被引量:1
  • 10Gauthier C, Langin D, Balligand JL. β3-adrenoceptors in the cardiovascular system[J]. Trends Pharmacol Sci, 2000, 21(11):426-431. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部